Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
80 hedge funds and large institutions have $319M invested in Syneron Medical Ltd in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 9 closing their positions.
1,404% more call options, than puts
Call options by funds: $376K | Put options by funds: $25K
145% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 11
133% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 9
27% more capital invested
Capital invested by funds: $252M → $319M (+$67M)
18% more funds holding
Funds holding: 68 → 80 (+12)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$9.1M |
| 2 |
SAM
Senzar Asset Management
New York
|
+$9.1M |
| 3 |
DM
Deerfield Management
New York
|
+$6.93M |
| 4 |
Millennium Management
New York
|
+$5.88M |
| 5 |
Renaissance Technologies
New York
|
+$3.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$22.5M |
| 2 |
VAM
Visium Asset Management
New York
|
-$16.7M |
| 3 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$16.3M |
| 4 |
RA
Royce & Associates
New York
|
-$3.54M |
| 5 |
HC
Hourglass Capital
Houston,
Texas
|
-$1.71M |
ELOS Hedge Fund Activity: Q1 2015 in Review
80 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q1 2015, worth a combined $319M — up 27% from $252M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new ELOS positions and 9 closed out — a net gain of 12 holders — while 27 added to existing stakes and 11 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $9.1M. The largest seller was Baupost Group, exiting entirely with an estimated $22.5M sold.
- 80 institutional investors held Syneron Medical Ltd (ELOS) as of Q1 2015, up from 68 in Q4 2014.
- Funds reported $319M of Syneron Medical Ltd stock for Q1 2015, up 27% quarter-over-quarter.
- 21 funds opened new Syneron Medical Ltd positions in Q1 2015 and 9 closed out, a net change of +12 holders.
- The largest Syneron Medical Ltd buyer in Q1 2015 was JP Morgan Chase, an estimated $9.1M added.
- The largest Syneron Medical Ltd seller in Q1 2015 was Baupost Group, an estimated $22.5M sold.
Based on aggregated 13F filings for Q1 2015.